Integra LifeSciences (IART)
(Real Time Quote from BATS)
$14.40 USD
-0.98 (-6.37%)
Updated Sep 19, 2025 03:32 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IART 14.40 -0.98(-6.37%)
Will IART be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IART based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IART
Should You Continue to Hold Integra Stock in Your Portfolio Now?
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
IART: What are Zacks experts saying now?
Zacks Private Portfolio Services
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
IART Stock May Rise on First Enrollment in AERA Pediatric Registry
Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?
Other News for IART
Is IART primed for upward momentum? Crossed Above 20 Day Moving Average shows up after gaining 3.92%
Is IART ready to move lower? 20 Day Moving Average Resistance shows up after declining 0.2%
IART forms Non-ADX 1,2,3,4 Bullish on September 16
20 Day Moving Average Support appears for IART after 0.07% move
MACD Bearish Signal Line Cross appears for IART after 2.65% move